Related Experiment Videos

Hemodynamic responses to pancuronium and vecuronium during high-dose fentanyl anesthesia for coronary artery bypass

R Paulissian1, M Mahdi, N J Joseph

  • 1Department of Anesthesiology, Illinois Masonic Medical Center, Chicago 60657.

Insights

Pancuronium, unlike vecuronium, increased myocardial ischemia during high-dose fentanyl anesthesia for coronary artery bypass grafting (CABG) surgery. Vecuronium showed fewer ischemic changes but caused bradycardia in patients on beta-blockers.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Pharmacology

Background:

  • High-dose fentanyl anesthesia is used for coronary artery bypass grafting (CABG).
  • Pancuronium and vecuronium are neuromuscular blocking agents used in anesthesia.
  • The hemodynamic and electrocardiographic (ECG) effects of these agents require careful evaluation in CABG patients.

Purpose of the Study:

  • To compare the hemodynamic and ECG effects of pancuronium and vecuronium.
  • To assess the incidence of myocardial ischemia associated with each muscle relaxant.
  • To evaluate the safety profile of pancuronium versus vecuronium in high-dose fentanyl anesthesia for CABG.

Main Methods:

  • A comparative study involving 48 patients undergoing elective CABG.
  • Patients received high-dose fentanyl anesthesia and either pancuronium or vecuronium.
  • Hemodynamic data and ECG tracings were collected at multiple time points before and after surgical interventions.

Main Results:

  • Pancuronium group (n=26) showed increased heart rate, cardiac index, and rate-pressure product, with 42.3% experiencing ischemic ECG changes.
  • Vecuronium group (n=22) had no significant increases in hemodynamic parameters, a decrease in cardiac index, and only 5.6% showed ischemic ECG changes.
  • Four patients in the vecuronium group on beta-blockers developed hypotension and bradycardia.

Conclusions:

  • High-dose fentanyl-pancuronium anesthesia is associated with a higher incidence of myocardial ischemia.
  • Vecuronium is associated with fewer myocardial ischemic changes compared to pancuronium.
  • Caution is advised with vecuronium in patients on beta-blockers due to potential bradycardia and hypotension.

Related Concept Videos